StockData
MDxHealth SA logo

MDxHealth SA (MDXH) stock

MDXHNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 3, 2026Score 5/30
$0.14−0.01 (-5.97%)

Close on Nov 18, 2026Market cap $719.62KP/E –Yield –

Earnings

MDxHealth's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q4 FY2021
$6.00M
EPS, Q4 FY2021
–
Latest guidance
Issued
Mar 3, 2022 · 1 item

Quarterly results

Revenue and earnings per share from each of MDxHealth's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2021ended Dec 31, 2021Mar 3, 2022after the close$6.00M––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

MDxHealth's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueFY2022$25.00M – $27.00M–NewMar 3, 2022

Guidance history

Every forecast MDxHealth put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 3, 2022revenueFY2022$25.00M – $27.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases MDxHealth filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?